Target intelligence / Profile preview

ATP-sensitive potassium channel (Sulfonylurea receptor 1-Inwardly rectifying potassium channel 6.2) (KATP channel)

Target
KATP channel
Molecular classification
Ion channel, Inwardly rectifying potassium channel, ATP-binding cassette transporter family, Hetero-octameric complex
01

Overview

The SUR1-Kir6.2 complex is a hetero-octameric ATP-sensitive potassium (KATP) channel that serves as a critical metabolic sensor in pancreatic beta cells and specific neuronal populations [1, 2, 4]. It is composed of four pore-forming inwardly rectifying potassium channel 6.2 (Kir6.2) subunits and four regulatory sulfonylurea receptor 1 (SUR1) subunits [2, 11, 14]. By sensing the intracellular ATP-to-ADP ratio, the channel couples cellular metabolism to membrane excitability; an increase in ATP leads to channel closure, membrane depolarization, and the subsequent release of insulin [1, 8, 11]. Dysregulation of this complex due to genetic mutations results in severe metabolic disorders, including neonatal diabetes (gain-of-function) and congenital hyperinsulinism (loss-of-function) [1, 4, 6, 11]. This channel is a major therapeutic target, with sulfonylurea drugs acting as blockers to stimulate insulin secretion in type 2 diabetes, while openers like diazoxide are used to suppress insulin overproduction in hypoglycemic conditions [12, 15].

Other names
SUR1-Kir6.2Pancreatic ATP-sensitive potassium channelABCC8-KCNJ11 complexBeta-cell KATP channelSulfonylurea receptor 1-Inwardly rectifying potassium channel 6.2 complex
02

Mechanism of action

Sulfonylureas and glinides act as channel blockers by binding to the SUR1 subunit, leading to channel closure, membrane depolarization, and stimulated insulin release [1, 8, 11, 12]. Conversely, potassium channel openers like diazoxide bind to SUR1 to maintain the channel in an open state, causing hyperpolarization and inhibition of insulin secretion [12, 15].

03

Biological functions

Signal transductionMetabolic sensingInsulin secretion regulationGlucose homeostasisNeuronal excitability
04

Disease associations

Type 2 diabetes mellitusCongenital hyperinsulinismNeonatal diabetes mellitusDEND syndrome
05

Safety considerations

HypoglycemiaHyperglycemiaOff-target cardiovascular effects due to SUR2 cross-reactivityFluid retentionHirsutism
06

Interacting drugs

Glibenclamide

7 more in the full profile.

07

Biomarkers

Blood glucoseSerum insulinC-peptideHbA1cABCC8 genetic mutationsKCNJ11 genetic mutations

Beyond the preview

Go deeper on ATP-sensitive potassium channel (Sulfonylurea receptor 1-Inwardly rectifying potassium channel 6.2) (KATP channel).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-sensitive potassium channel (Sulfonylurea receptor 1-Inwardly rectifying potassium channel 6.2) (KATP channel).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call